Research programme: antibody-based therapeutics - Lumen Bioscience/Tufts University
Alternative Names: Oral monoclonal antibody cocktail - Lumen Bioscience; Spirulina-based antibody therapeuticsLatest Information Update: 28 Feb 2025
At a glance
- Originator Lumen Bioscience; Tufts University
- Class Anti-inflammatories; Antibacterials; Antibodies; Antidiarrhoeals
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diarrhoea; Gastrointestinal disorders
Most Recent Events
- 28 Feb 2025 No recent reports of development identified for research development in Diarrhoea(Prevention) in USA (PO)
- 28 Feb 2022 No recent reports of development identified for preclinical development in Gastrointestinal-disorders in USA (PO)
- 28 Jan 2021 Early research in Diarrhoea (Prevention) in USA (PO)